AbbVie Operating Income increased by 138.7% to $4.54B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Operating Income shows a downward trend with a -5.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
is_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.44B | $4.31B | $5.07B | $4.72B | $3.30B | $4.60B | $5.50B | $2.77B | $4.51B | $2.28B | $3.20B | $2.80B | $4.00B | $3.83B | $3.73B | $4.89B | $1.90B | $4.54B |
| QoQ Change | — | -3.0% | +17.8% | -7.0% | -30.1% | +39.7% | +19.5% | -49.7% | +63.0% | -49.5% | +40.1% | -12.4% | +42.9% | -4.2% | -2.6% | +31.1% | -61.1% | +138.7% |
| YoY Change | — | — | — | — | -25.8% | +6.9% | +8.4% | -41.3% | +37.0% | -50.4% | -41.9% | +1.1% | -11.4% | +68.0% | +33.4% | +22.4% | -50.3% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.